Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by consultant99on Jan 12, 2020 2:28pm
239 Views
Post# 30544150

Chart Pattern

Chart Pattern

For what it is worth I took a look at the TLT chart and TD Waterhouse technical service. They identified this as a rounded bottom pattern on a weekly chart Jan 3rd 2020 with an expected long-term price (9+ months) of $0.61 to 0.63/share. 

How effective are these signals? I find they work best when they align with fundamental news that support the price target. Jan 31st 2019 there was another long term buy signal based on a bottom wedge pattern with a target of 0.60 to 0.66/share. TLT as you recall got up to 0.60/share last year on March 5th - much quicker than expected.

There is a worrisome price gap between 0.25 and 0.26/share (Dec 10 and 11th); gaps do tend to get filled. TD notes overhead resistance at 0.33/share- not surprising as we are under the 50 day and 200 week moving averages at 0.31 and the 200 day ma at 0.34 with support way back at 0.22/share.

Looking at the move from 0.20 to 0.39 I expected a normal correction to take the price back to the 0.28 to 0.31 level. If the gap were to get filled it hopefully will be a very brief inter-day sell off followed by a rebound. It might take some news to propel the price through the moving averages and then keep it there. 

The longer term pattern is bullish assuming no chnages in the company fundamentals.There is some short-term price weakness and uncertainty to deal with. Based on the speed of the upturn in prices a year ago those 0.54 warrants might still be in play and some or all could be exercised before they expire.

If I really wanted to own the stock I would be buying under 0.30 if I could get it and forget about those warrants as having much if any value.




 

Bullboard Posts